Effects of Aramchol in patients with nonalcoholic fatty liver disease (NAFLD). A systematic review and meta-analysis

Effects of Aramchol in patients with nonalcoholic fatty liver disease (NAFLD). A systematic review and meta-analysis

Bibliographic Details
Main Authors:	Adnan Malik, Mahum Nadeem, Waseem Amjad, Muhammad Imran Malik, Sadia Javaid, Umer Farooq, Khadija Naseem, Ahmad Khan
Format:	Article
Language:	English
Published:	Termedia Publishing House 2022-02-01
Series:	Gastroenterology Review
Subjects:	non-alcoholic fatty liver disease aramchol meta-analysis
Online Access:	https://www.termedia.pl/Effects-of-Aramchol-in-patients-with-nonalcoholic-fatty-liver-disease-NAFLD-A-systematic-review-and-meta-analysis,41,46420,1,1.html

Similar Items

Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis
by: Dipankar Bhattacharya, et al.
Published: (2021-06-01)

The Effect of Licorice and Probiotics on Nonalcoholic Fatty Liver Disease (NAFLD): A Systematic Review
by: Pouya Rostamizadeh, et al.
Published: (2019-12-01)

Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis
by: Xuefeng Ma, et al.
Published: (2020-01-01)

Effects of various interventions on non-alcoholic fatty liver disease (NAFLD): A systematic review and network meta-analysis
by: Xinchen Wang, et al.
Published: (2023-03-01)

Nutritional Management in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Sepideh Mahboobi, et al.
Published: (2015-07-01)

Nonalcoholic fatty liver disease (NAFLD) among older adults
by: Panyavee Pitisuttithum, et al.
Published: (2022-12-01)

The Effect of Psyllium on Anthropometric Measurements and Liver Enzymes in Overweight or Obese Adults with Nonalcoholic Fatty Liver Disease (NAFLD)
by: Zahra Akbarzadeh, et al.
Published: (2015-12-01)

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
by: Hyo Young Lee, et al.
Published: (2019-03-01)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease
by: Jong Hwa Choi, et al.
Published: (2020-10-01)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
by: Lucia Carulli, et al.
Published: (2019-02-01)

Non-Alcoholic Fatty Liver Disease (NAFLD) in Obesity
by: Rushad Patell, et al.
Published: (2014-01-01)

Phosphatidylethanolamines Are Associated with Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Adults and Induce Liver Cell Metabolic Perturbations and Hepatic Stellate Cell Activation
by: Samaa Shama, et al.
Published: (2023-01-01)

Prevalence of the Absence of Cirrhosis in Subjects with NAFLD-Associated Hepatocellular Carcinoma
by: Marco Castellana, et al.
Published: (2021-10-01)

Non Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure
by: Alabagi Abdulla, et al.
Published: (2016-04-01)

Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Marcin Kosmalski, et al.
Published: (2022-09-01)

Effect of mediterranean diet on non-alcoholic fatty liver disease (NAFLD)
by: Patrycja Walczak, et al.
Published: (2023-01-01)

Obesity and nonalcoholic fatty liver disease: current perspectives
by: Sarwar R, et al.
Published: (2018-09-01)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023-02-01)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
by: Ji-Won Park, et al.
Published: (2023-04-01)

What’s New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Marcin Kosmalski, et al.
Published: (2023-02-01)

Historical narrative from fatty liver in the nineteenth century to contemporary NAFLD – Reconciling the present with the pastKey points
by: Oyekoya T. Ayonrinde
Published: (2021-06-01)

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)
by: Yuan-Ye Qiu, et al.
Published: (2023-06-01)

Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
by: Kalliopi Pafili, et al.
Published: (2021-08-01)

Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?
by: Julia A. Golubeva, et al.
Published: (2023-09-01)

Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
by: Karn Wijarnpreecha, et al.
Published: (2021-04-01)

Leptin in nonalcoholic fatty liver disease
by: Billur Canbakan, et al.
Published: (2008-07-01)

The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease
by: Marina Nati, et al.
Published: (2021-08-01)

Implications of comorbidities in nonalcoholic fatty liver disease
by: Sherlot Juan Song, et al.
Published: (2023-04-01)

Gut microbiota and nonalcoholic fatty liver disease
by: Boyeon Kim, et al.
Published: (2023-09-01)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
by: Dae Ho Lee
Published: (2020-06-01)

Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
by: Menooa Ebrahimi, et al.
Published: (2023-03-01)

Effects of coenzyme Q10 supplementation on lipid profiles and liver enzymes of nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta‐analysis of randomized controlled trials
by: Ali Ardekani, et al.
Published: (2023-06-01)

The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
by: Jun Sung Moon, et al.
Published: (2013-08-01)

Treatments for NAFLD: State of Art
by: Alessandro Mantovani, et al.
Published: (2021-02-01)

Factors contributing to nonalcoholic fatty liver disease (NAFLD) and fat deposition after pancreaticoduodenectomy: A retrospective analysis
by: Hideki Izumi, et al.
Published: (2023-09-01)

Influence of surgical treatment of obesity on the course of nonalcoholic fatty liver disease
by: A. S. Pushkareva, et al.
Published: (2023-11-01)

Clinical and Pathogenetic Parallels of Nonalcoholic Fatty Liver Disease and Gallstone Disease
by: Aleksey O. Bueverov
Published: (2019-03-01)

Nonalcoholic Fatty Liver Disease (NAFLD) And Cardiovascular Risk In Renal Transplant Recipients
by: Ivana Mikolasevic, et al.
Published: (2014-09-01)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
by: Li Rong, et al.
Published: (2023-01-01)

Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis
by: Sun Y, et al.
Published: (2019-01-01)